The NIH says the information will help researchers find the genetic underpinnings of adult diseases.
The company's set of 10 sequencers brings down genome decoding to $1,000 each.
The three drugmakers launched into a series of sell-offs and acquisitions over the weekend.
Regulators say the company has not received approval for the device's touted functions.
The diagnostics firm is undercutting Myriad's cost by almost $1,000.
23andMe aired its first TV ad Monday, in a bid to build the audience for DNA sequencing.
Merely isolating genes can't win you a patent, said the Supreme Court -- and that stands to fuel scientific inquiry in the age of personalized medicine
Pfizer Oncology has recruited Desperate Housewives and West Wing star Kathryn Joosten to feature in a national education campaign titled Lung Cancer Profiles, which aims to reduce stigma and plug molecular testing of the disease as the company deepens its investment in genetically-targeted oncology therapies.
Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.